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Abstract Hsp27 belongs to the small heat shock pro-
tein family, which are ATP-independent chaperones.
The most important function of Hsp27 is based on its
ability to bind non-native proteins and inhibit the ag-
gregation of incorrectly folded proteins maintaining
them in a refolding-competent state. Additionally, it
has anti-apoptotic and antioxidant activities. To study
the effect of Hsp27 on memory and synaptic functions,
amyloid-β (Aβ) accumulation, and neurodegeneration,
we generated transgenic mice overexpressing human Hsp27
protein and crossed with APPswe/PS1dE9 mouse strain, a
mouse model of Alzheimer's disease (AD). Using different
behavioral tests, we found that spatial learning was impaired
in ADmodel mice and was rescued by Hsp27 overexpression.
Electrophysiological recordings have revealed that excitabili-
ty of neurons was significantly increased, and long-term po-
tentiation (LTP) was impaired in AD model mice, whereas
they were normalized in Hsp27 overexpressing AD model
mice. Using anti-amyloid antibody, we counted significantly
less amyloid plaques in the brain of APPswe/PS1dE9/Hsp27
animals compared to AD model mice. These results suggest
that overexpression of Hsp27 protein might ameliorate certain
symptoms of AD.
Keywords Heat shock proteins . Transgenic mice . Mouse
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Introduction
AD is one of the most common neurodegenerative diseases,
and its prevalence is strongly correlated with aging (Evans
et al. 1989). AD is characterized by progressive loss of
memory and cognitive functions (McKhann et al. 1984).
The pathological hallmarks of AD are extracellular amyloid
plaque deposition, formation of intracellular neurofibrillary
tangles, and other alterations in the brain such as activation
of microglial cells, oxidation of lipids, induction of reactive
oxygen species, disruption of neuronal metabolic homeosta-
sis, and neuronal cell death (Serrano-Pozo et al. 2011; Monji
et al. 2001). Amyloid plaques and neurofibrillary tangles are
present mainly in brain regions involved in learning, mem-
ory, and emotional behaviors, primarily in the hippocampus
(Mattson 2004).
Heat shock proteins (Hsps) are ubiquitously expressed
evolutionary conserved proteins which are upregulated by
different stressors and also in various pathological condi-
tions. Most of the stress-induced proteins are molecular
chaperons, and they have an essential role in biosynthesis,
transport, translocation, folding, and assembly of other pro-
teins (Morimoto et al. 1992). Under stress, Hsps prevent
protein misfolding and oligomerization, and they transfer
misfolded proteins to the proteasome for degradation
(Becker and Craig 1994). They also assist in the mainte-
nance of normal cellular homeostasis and metabolism.
Hsp27 belongs to the small heat shock protein (sHsp)
family, which are ATP-independent chaperones (Jakob et al.
1993). The most important function of sHsps is that they can
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inhibit the aggregation of incorrectly folded proteins by
binding to non-native proteins, and maintain them in a
refolding-competent state (Haslbeck and Buchner 2002).
Moreover, they also have anti-apoptotic and antioxidant
activities and can bind to the actin cytoskeleton and stabilize
it (Arrigo et al. 2002, Preville et al. 1999, Wang and Spector
1996).
Hsps are upregulated in several neurodegenerative
diseases and can protect brain cells against free radical
injury, oxidative stress, and misfolded proteins (Kalmar
and Greensmith 2009). Several studies indicate that
chaperones are potent suppressors of neurodegeneration
and are, therefore, promising therapeutic targets for pro-
tein conformational disorders (reviewed inMuchowski and
Wacker 2005). For example, treating a polyglutamine disease
model with an antiulcer drug, geranylgeranylacetone (GGA),
which can induce the expression of different Hsps, could
suppress the accumulation of pathogenic proteins and amelio-
rate the related phenotype (Katsuno et al. 2005). In a rat model
of Parkinson's disease, Hsp104 was found to be similarly
efficient (Lo Bianco et al. 2008). An increased level of ex-
pression of small Hsps and Hsp70 in the brain of AD patients
has been reported in a number of studies (Perez et al. 1991;
Muchowski and Wacker 2005). Several studies suggest that
expression of Hsps could suppress the progression of AD
(Magrané et al. 2004; Muchowski and Wacker 2005; Evans
et al. 2006). Hoshino et al. (2011) investigated the effect of
overexpression of Hsp70 on AD-related phenotypes, using
double transgenic mice overexpressing Hsp70 and a mutant
(Swedish) type of APP (APPswe). They demonstrated that
overexpression of Hsp70 inhibited the development of the
pathological phenotype of AD and the resultant cognitive
deficit, possibly through its effects on antiaggregation,
neuroprotection, and stimulation of Aβ clearance.
To study the effect of a small heat shock protein,
Hsp27, on memory and synaptic functions, Aβ accumu-
lation, and neurodegeneration, we generated transgenic mice
overexpressing the human Hsp27 protein and crossed them with
the APPswe/PS1dE9 mouse strain, a widely used mouse model
of AD.
Materials and methods
Animals
The study conformed to EU Directive 2010/63/EU and
was approved by the regional Station for Animal Health
and Food Control (Csongrád, Hungary) under project
license XVI/02752/2009. Mice were housed in groups
of two to three under standard conditions (24 °C, 12 h
light–dark cycle) with food and water available ad
libitum.
Generation of APPswe/PS1dE9/Hsp27 transgenic mice
We have previously generated transgenic mice overexpressing
the human Hsp27 protein on FVB genetic background (Tóth
et al. 2010). Transgenic DNA construct contained the human
Hsp27 cDNA driven from a cytomegalovirus (CMV) promot-
er. This transgenic line was crossed with C57BL/6 mice four
times in order to establish a Hsp27 transgenic line on a
homogenous C57BL/6 genetic background. B6C3-
Tg(APPswe/PS1dE9)85Dbo/Mmjax mice were purchased
from The Jackson Laboratory (Bar Harbor, ME, USA) and
maintained onC57BL/6 genetic background. Hsp27 transgen-
ic mice then were crossed with APPswe/PS1dE9 mice to
generate APPswe/PS1dE9/Hsp27 multiple transgenic strain.
To identify the genotype of the offsprings, polymerase chain
reaction (PCR) was performed from tail biopsies using the
following primers: 5′-GTC CCT GGATGT CAA CCA CT-3′
and 5′-GAC TGG GAT GGT GAT CTC GT-3′ for Hsp27; 5′-
GAC TGA CCA CTC GAC CAG GTT CTG-3′ and 5′-CTT
GTAAGTTGGATTCTCATATCCG-3′ for APP(Swe); and
5′-AATAGAGAACGGCAGGAGCA-3′ and 5′-GCCATG
AGG GCA CTA ATC AT-3′ for PS1dE9. The PCR amplifi-
cation was done in a MJ Research PTC-200 Thermal Cycler
using the following parameters: denaturation at 95 °C for
4 min followed by 29 cycles of denaturation at 95 °C for
1 min, annealing at 56 °C for 1 min and elongation at 72 °C
1 min, and a final extension at 72 °C for 4 min.
Western blot analysis
Expression of Hsp27 was determined from cortical and
hippocampal tissues of 7 months old transgenic mice
and wild type littermates. For ApoA1 protein level
estimation, whole brain tissue was used. Total protein
was isolated from frozen tissues homogenized in lysis
buffer (containing 50 mM Tris–HCl, 150 mM NaCl, 1 %
Triton X-100, 0.5 % Na deoxycholate, 0.1 % SDS, and
protease inhibitor), centrifuged at 10,000 rpm for 10 min at
4 °C, and the supernatant was used for western blot analysis.
Protein concentration was measured at 280 nm using a
NanoDrop spectrophotometer (NanoDrop Technologies).
Protein samples (50 μg) were separated by 10 % SDS-
PAGE (Cambrex) and transferred electrophoretically onto
Hybond-P PVDF membrane (Amersham). Membrane was
blocked for 1 h in 5 % milk powder. After a short wash in
PBS-Tween buffer, membrane was incubated with anti-Hsp27
(1:500, Stressgen, Cat No: SPA-803), anti-ApoA1 (1:250,
Rockland, Cat. No: 600-101-196), and anti-β-actin (1:1,400,
Sigma, Cat. No: A2103) antibodies overnight at 4 °C. After a
brief wash, membranes were incubated with anti-goat
(1:10,000, Jackson ImmunoResearch, Cat. No: 305-035-
003) or anti-rabbit (1:35,000, Jackson ImmunoResearch,
Cat. No: 111-035-003) secondary antibodies for 45 min at
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room temperature. Signals were developed using Luminata
Forte Western HRP Substrate (Millipore) according to the
manufacturer's instructions. Signal intensities were quantified
using ImageJ 1.45 software.
Behavioral tests
For behavioral testing, 7-month-old male mice were
used. Before starting the tests, mice were handled daily
for 2 weeks. Behavioral tests were performed between
9:00 a.m. and 4:00 p.m. Tests were recorded by video
camera, and data were analyzed by EthoVision 2002
computer-controlled video tracking system (The Noldus
Information Technology, The Netherlands).
Open field
Locomotor activity and anxiety-like behavior were studied
using open field test. Each mouse was placed in the center of
a plastic oval arena (50×70×30 cm) virtually divided into
central and peripheral areas by the software. Total distance
travelled (in centimeters), number of rearings, time spent
with grooming, and time spent in the peripheral areas were
measured. Data were collected for 5 min. All animals were
tested once.
Barnes maze test
In the Barnes maze test, using a bright light, animals
were reinforced to escape from the open platform sur-
face to a small dark chamber located under the platform
called “target box.” The experiment was performed
according to a technique published on the internet
(Sunyer et al. 2007). The maze consisted of a circular
platform (100 cm in diameter) with 20 holes (hole
diameter, 5 cm) along the perimeter. The circular open
field was elevated 90 cm from the floor. A black escape
(target) box (19×6×7 cm) was located under one of the
holes. The location of the target box was consistent for
any given mouse, but was randomized across mice. The
platform was surrounded by curtains and visual cues on
it to help the mice with orientation. Mice were placed
in the middle of the maze and were free to explore it.
The trial ended after 3 min or when the mouse entered
the escape box. When a mouse entered the escape box,
it was allowed to stay in it for 1 min. If the mouse did
not find the escape box, it was guided to it and left
inside for 1 min. One trial per day was performed for
five consecutive days. Time of latency to enter the
target box was measured. On day 8, the probe trial
was performed without the escape box to confirm that
this spatial task was acquired based on navigation using
distal-environment room cues. The trial ended after
2 min. Time of latency to reach the target hole was
measured.
Morris water maze test
For the Morris water maze test, a circular pool (130 cm
in diameter and 60 cm in height) was filled to a height
of 45 cm with water. Water temperature was maintained
between 22 °C and 23 °C, and it was made opaque by
mixing milk in it. For the invisible platform test, a
white colored platform (5 cm in diameter) was placed
at the center in one of four quadrants of the pool
(training quadrant) and submerged 1 cm below the
water surface so that it was invisible at water level.
The pool was surrounded by curtains, and different
spatial cues were attached to the curtains to help the
mice with orientation. The location of the platform was
fixed at the same quadrant while the start position of
swimming was varied. Mice were given two trials per
day for five consecutive days, during which they were
allowed to find the platform within 90 s. Once the
mouse located the platform, it was permitted to stay
on it for 10 s. If the mouse did not find the platform
within 90 s, it was guided to the platform and placed
on it for 10 s. The escape latency, the time required for
the mouse to find and climb onto the platform, was
recorded. The means of the data from each day were
used for statistics. Some of the mice have shown float-
ing behavior in the Morris water maze test. This means
that mice remained motionless most of the time during
the trial period. These mice were also very passive in
the Barnes maze test. We counted the trials when mice
showed floating/passive behavior and found that three
mice were motionless almost in the 70 % of trials;
therefore, these mice were excluded from the behavioral
tests.
Immunohistochemistry
Subsequent to the behavioral tests, mice were sacrificed by
cervical dislocation, and the brains were removed for further
studies. Frozen sections (10 μm) of the brains were
processed for immunohistochemistry. Sections were fixed
in acetone for 3 min. After a brief wash with PBS, sections
were incubated with 1.5 % H2O2 in methanol for 20 min
then with 3 % H2O2 for 20 min to block endogenous
peroxidases. PBS wash was followed by collagenase treat-
ment using 0.1 mg/ml collagenase type II (Sigma) in a
buffer containing 0.25 M NaCl, 50 mM Tris–HCl, pH 7.4,
and 1 mM EDTA at 37 °C for 5 min. After a brief wash in
PBS, sections were incubated in 5 % goat serum for 1 h at
room temperature to prevent nonspecific binding of the
antibody. Sections were then covered with anti-Aβ [1–42]
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(1:60, Invitrogen, Cat No. 700254), anti-cleaved caspase-3
(1:50, Cell Signalling, Cat. No. Asp-175), or with anti-
Hsp27 (1:50, Stressgen, Cat No: SPA-803) primary anti-
bodies overnight at 4 °C. Slides were washed with PBS,
then goat anti-rabbit secondary antibody (1:150, Jackson
ImmunoResearch, Cat. No.111-035-003) was applied for
45 min. After washing, slides were incubated with develop-
ing reagent (10 % dimethyl formamide, 10 % imidazole,
0.02 % aminoethyl carbazole, 0.04 % H2O2) at room tem-
perature until the brown color appeared (approximately
10 min). Sections were then counterstained with hematoxy-
lin solution for 2 min at room temperature followed by
washing with PBS, and they were covered with glycerol
gelatin.
For Aβ [1–42] and cleaved capase-3 antibody
stainings, 7-month-old transgenic (n=6) and wild type
(n=6) animals were used. Stained sections were
photographed using a light microscope equipped with
CCD camera, and amyloid plaques or apoptotic cells
were counted in 15 microscopic fields by two indepen-
dent individuals.
Fluoro-Jade C staining
Brains were removed, and 10-μm acetone-fixed frozen
sections were prepared. Slides were immersed into ab-
solute ethanol for 5 min, then rinsed in 70 % ethanol
for 2 min, in 30 % ethanol for an additional 2 min, and
finally in distilled water for 2 min. Sections then were
incubated in 0.06 % potassium permanganate solution
for 30 min. Following a 2-min water rinse, sections
were transferred into a 0.0004 % solution of Fluoro-
Jade C (Chemicon) fluorescent dye dissolved in 0.1 %
acetic acid. Slides were washed three times in distilled
water for 1 min. After drying, sections were cleared in
xylene for 2 min and coversl ipped with DPX
nonfluorescent mounting media. Degenerating neurons
emitting green fluorescence were visualized under
Nikon Eclipse E600 fluorescent microscope using a
520-nm fluorescein filter set. Six 7-month-old animals
from each group were selected, and two slides of each
animal's brain were stained using Fluoro-Jade C dye.
On each slide, 15 digital photographs were taken, and
degenerating neurons were counted by two independent
individuals.
Hippocampal slice electrophysiology
Following standard procedures, 400-μm-thick transverse
hippocampal slices were prepared from the brain of 7-
month-old mice using a McIlwain tissue chopper (Campden
Instruments, Loughborough, UK). Slices were incubated in
standard artificial cerebrospinal fluid (ACSF) at ambient
temperature for 60 min, which was constantly gassed with
95 % O2–5 % CO2. ACSF contained (millimolar) NaCl,
130; KCl, 3.5; CaCl2, 2; MgCl2, 2; NaH2PO4, 0.96;
NaHCO3, 24; D-glucose, 10 (pH 7.4). Individual slices were
transferred to a 3D-MEA chip with 60 tip-shaped and
60-μm-high electrodes spaced by 200 μm (Ayanda
Biosystems, S.A., Lausanne, Switzerland). The slice was
continuously perfused with oxygenated ACSF (1.5 ml/min
at 36 °C) during the whole recording session. Data were
recorded by a standard, commercially available MEA setup
(Multi-Channel Systems MCS GmbH, Reutlingen, Germa-
ny). The Schaffer collateral was stimulated by injecting a
biphasic voltage waveform (−100/+100 μs) through one
selected electrode at 0.033 Hz. Care was taken to choose
the stimulating electrode in the same region from one slice
to the other. The peak-to-peak amplitudes of fEPSPs at the
stratum pyramidale and stratum radiatum of CA1 were
analyzed. After a 30-min incubation period, the threshold
and the maximum of stimulation intensity for evoked re-
sponses was determined. For evoking responses, 30 % of the
maximal stimulation intensity was used.
Following a stable 10-min control sequence, the stimulus
intensity was continuously increased from 400 to 3,200 mV
with 400 mV steps (input/output curve). Paired-pulse pro-
tocol consisted of two stimulation pulses injected with
interstimulus intervals of 20, 50, 200, and 500 ms with
0.033 Hz. Three data points were obtained at every stimu-
lation intensity/interstimulus intervals at the input/output
curve and paired-pulse protocol. LTP was induced using a
theta-burst stimulation (TBS) pattern applied at the maxi-
mum stimulation intensity. TBS comprised a train with ten
bursts given at 5 Hz per train and four pulses given at
100 Hz per burst.
RNA extraction and quantitative real-time PCR
For quantitative real-time PCR (Q-PCR), 6-month-old
Hsp27 transgenic (n=3) and wild type mice (n=3) were
used. Total RNA was extracted from whole brain using
Trizol reagent (Invitrogen), according to the manufacturer's
protocol. RNA samples then were cleaned using
NucleoSpin RNA Clean-up columns (Macherey-Nagel)
and treated with DNaseI (Macherey-Nagel) for 30 min.
First-strand cDNA was synthesized by reverse transcription
(5 μg RNA/30 μl reaction volume) using High-Capacity
cDNA Archive kit (Applied Biosystems). The temperature
profile of the reaction was as follows: 10 min at room
temperature, 2 h at 37 °C, 5 min on ice, and finally,
10 min at 75 °C.
Q-PCR was performed on a RotorGene 3000 instrument
(Corbett Research, Sydney, Australia) using gene-specific
primers listed in Table 1. The cDNA was diluted 1:20, and
9 μl of this mix was used as a template in the reaction.
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Reactions were performed in a total volume of 20 μl
containing 10 μl of FastStart SYBR Green Master mix
(Roche) and 5 mM of each primer. The amplification was
carried out with the following cycling parameters: 15 min
heat activation at 95 °C, followed by 45 cycles denaturation
at 95 °C for 25 s, annealing at 60 °C for 25 s, and extension
at 72 °C for 20 s. Fluorescent signals were collected after
each extension step at 72 °C. Relative expression ratios were
normalized to β-actin.
Statistical analysis
All data obtained in this experiment were expressed as
mean ± SEM. Statistical analysis was performed by one-way
analysis of variance (ANOVA) followed by Fisher's post hoc
test using OriginPro8 software. Electrophysiological data
were analyzed by two-way ANOVA followed by Tukey's post
hoc test. The level of statistical confidence was set at p<0.05.
Results
Generation of transgenic mice
Transgenic mice overexpressing the human Hsp27 protein
were generated in our laboratory as described earlier (Tóth
et al. 2010). By crossing the human Hsp27 overexpressing
mice with the APPswe/PS1dE9 mouse strain, we generated
a triple transgenic mouse strain. The APPswe/PS1dE9 strain
(The Jackson Laboratory, Bar Harbor, ME, USA) is a wide-
ly used mouse model of AD (Jankowsky et al. 2004,
Reiserer et al. 2007, Hamilton and Holscher 2012), and it
shows several symptoms of the disease including impaired
spatial learning, reduced long-term potentiation, widespread
amyloid deposition, and mild neurodegeneration (The Jackson
Laboratory (2013)) (http://jaxmice.jax.org/strain/004462.html).
First, cerebral expression of the Hsp27 transgene was
investigated. Using western blot analysis, robust expression
of human Hsp27 was detected in the cortical and hippocampal
tissues of Hsp27 and triple transgenic (AD/Hsp) brains, while
no expression was found in wild type and APPswe/PS1dE9
(AD) littermates (Fig. 1a). Hsp27 expression was also
confirmed in the brain of Hsp27 and APPswe/PS1dE9/Hsp27
animals using immunohistochemical staining (Fig. 1b). While
Hsp27 antibody stained hippocampal tissues of Hsp27 trans-
genics homogeneously, it showed a spotted, plaque-like
staining pattern in the hippocampal region of APPswe/
PS1dE9/Hsp27 brains (Fig. 1c).
Behavioral tests
Seven-month-old male mice were divided into three exper-
imental groups: an AD mouse model group (APPswe/PS1dE9,
n=11), an APPswe/PS1dE9/Hsp27 triple transgenic group (n=
12), and a wild type group (n=9).
Locomotor activity
First, locomotor activity (total distance travelled), explor-
atory behavior (number of rearings), and anxiety (time spent
on the periphery, time spent with grooming) were recorded
using open field test. There was no significant difference
between groups in these behavioral features (total distance
travelled, p=0.25; rearings, p=0.34; time spent on periph-
ery, p=0.33; grooming, p=0.64).
Barnes maze test
Spatial learning and memory were tested using Barnes
maze and Morris water maze tests. Both tests are based
on spatial navigation, and the performance of the ani-
mals depends on hippocampal function (Kennard and
Woodruff-Pak 2011). In Barnes maze test, APPswe/PS1dE9
mice spent more than 130 s with searching the escape box on
Table 1 List of Q-PCR primers used in this study
Gene Forward primer Reverse primer
Amyloid precursor protein (APP) TACTGCATGGCGGTGTGT CGTGGGAAGTTTATCAGGATCT
Apolipoprotein-AI (ApoAI) TATGTGGATGCGGTCAAAGA TGAACCCAGAGTGTCCCAGT
Apolipoprotein-D (ApoD) GAAGGCTTTTACAGGCTCCA GGCCAGGAACATCAGCAT
Apolipoprotein-E (ApoE) CAATTGCGAAGATGAAGGCTC TAATCCCAGAAGCGGTTCAG
Nitric oxide synthase-1 (Nos1) CATCAGGCACCCCAAGTT CAGCAGCATGTTGGACACA
Nitric oxide synthase-3 (Nos3) CCAGTGCCCTGCTTCATC GCAGGGCAAGTTAGGATCAG
LDL receptor-related protein-1 (Lrp1) ACCACCATCGTGGAAAATG GTCCCAGCCACGGTGATA
LDL receptor-related protein-2 (Lrp2) GATGGATTAGCCGTGGACTG TCCGTTGACTCTTAGCATCTGA
Low-density lipoprotein receptor (LDLr) CAAGAGGCAGGGTCCAGA CCAATCTGTCCAGTACATGAAGC
Heat shock protein 90 (Hsp90) GTCTCGTGCGTGTTCATTCA CATTAACTGGGCAATTTCTGC
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each day of the training period. In contrast, wild type and
APPswe/PS1dE9/Hsp27 mice learned soon to find the escape
hole as indicated by the reduction of escape latency. On the
fourth day, mice from the wild type group spent 76 s with
searching and performed significantly better than
APPswe/PS1dE9 mice (140 s; p<0.05; Fig. 2a). However,
there was no significant difference between the performance of
wild type and APPswe/PS1dE9/Hsp27 mice. On the fifth day,
the escape latency of the wild type and APPswe/PS1dE9/Hsp27
groups were 92 and 72 s, respectively, performing significantly
better then APPswe/PS1dE9mice (169 s; p<0.01 and p<0.001),
and again, there was no significant difference between
APPswe/PS1dE9/Hsp27 and wild type groups (Fig. 2a). The
probe trial was performed 3 days after the last training session.
The result of the probe trial was similar to the previous trial; wild
type and APPswe/PS1dE9/Hsp27 mice found the correct target
hole within 50 and 41 s, respectively, and these were signif-
icantly shorter compared to APPswe/PS1dE9 mice (93 s; p<
0.05 and p<0.01). No statistical difference was observed
between wild type and APPswe/PS1dE9/Hsp27 groups
(Fig. 2b).
Morris water maze test
Spatial learning was also tested using Morris water maze to
confirm the result of Barnes maze test. On the third day,
wild type mice find the escape platform in 41 s on average,
and this was significantly shorter compared to APPswe/PS1dE9
group (76 s, p<0.01; Fig. 2c). On the fourth day, the escape
latency of the wild type andAPPswe/PS1dE9/Hsp27 groupswas
52 and 50 s, respectively, performing significantly better than
APPswe/PS1dE9 mice (74 s; p<0.05). There was no difference
Fig. 1 a Detection of human
Hsp27 expression in the
hippocampus and cortex of wild
type (Wt), APPswe/PS1dE9
(AD), APPswe/PS1dE9/Hsp27
(ADHsp), and Hsp27
transgenic mice (Hsp27) using
western blot analysis. b Hsp27
immunostaining of brain
sections of 7 months old wild
type (Wt), Hsp27 transgenic
(Hsp27), APPswe/PS1dE9, and
APPswe/PS1dE9/Hsp27 mice.
Brown staining indicates
human Hsp27
immunoreactivity (black
arrows). Nuclei were
counterstained with
hematoxylin. Scale bar
indicates 100 μm. c Higher
magnification of the
hippocampal region of Hsp27
transgenic and APPswe/
PS1dE9/Hsp27 mice stained by
anti-Hsp27 antibody. Black
arrows indicate a plaque-like
staining of Hsp27. Scale bar
represents 100 μm
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between the performance of APPswe/PS1dE9/Hsp27 and wild
type groups (Fig. 2c). Interestingly, on the last day of training
sessions, there was no statistical difference between groups, and
the performance of most animals has declined.
Hippocampal slice electrophysiology
Hippocampal function was studied using paired-pulse facil-
itation (PPF) and long-term potentiation (LTP). Excitability
Fig. 2 Assessment of learning
and memory using behavioral
assays. Cognitive behavior of
7 months old wild type (WT,
n=9), APPswe/PS1dE9 (n=11),
and APPswe/PS1dE9/Hsp27
(n=12) transgenic mice were
compared. Escape latency in
seconds during training session
(a) and probe test of the Barnes
maze test (b). Escape latency in
seconds in Morris water maze
test (c). Mean ± SEM is shown;
*p<0.05; **p<0.01;
***p<0.001
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of neurons was studied at stimulation intensity of 0.4, 0.8,
1.2, 1.6, 2.0, 2.4, 2.8, and 3.2 V. Slices prepared from brains
of AD model (APPswe/PS1dE9) mice showed an elevated
fEPSP increase at the same stimulus intensity compared to
control, indicating an increased excitability of neurons (p≤
0.05, two-way ANOVA; Fig. 3a). This increased synaptic
excitability was normalized in APPswe/PS1dE9/Hsp27
mice (Fig. 3a). However, paired-pulse facilitation did not
differ significantly among the groups, indicating that pre-
synaptic function was unaffected by the genotype (Fig. 3b).
LTP is a cellular correlate of learning and memory. We
found that LTP was impaired in the APPswe/PS1dE9 group
(125±6 % vs. 154±6 % in the wild type, p≤0.05), but this
was partially rescued in the APPswe/PS1dE9/Hsp27 geno-
type mice (144±8 %; Fig. 3c, d).
Amyloid staining
Amyloid plaque formation was studied by immunostaining of
frozen brain sections of 7-month-old transgenic and wild type
mice using anti-Aβ [1–42] antibody. Numerous amyloid de-
posits were observed in the hippocampus and cortex of
APPswe/PS1dE9 transgenic animals (0.99/field of view and
1.08/field of view, respectively), in contrast to wild type
animals (0.02/field of view in the hippocampus and 0.06/field
of view in the cortex; Fig. 4a, b). Amyloid plaques were
detected in APPswe/PS1dE9/Hsp27 brains as well (0.69/field
of view in the hippocampus and 0.78/field of view in the
cortex; Fig. 4a, b); however, the number of plaques was
significantly less in both regions than in APPswe/PS1dE9
group (p<0.05; Fig. 4c), indicating that Hsp27 might prevent
Fig. 3 Electrophysiological recordings on hippocampal slices from
7 months old mice. a Neuronal excitability of transgenic mice at
different stimulation intensities. Data was analyzed by two-way
ANOVA followed by Tukey's test. Asterisk denotes p<0.05. b Assess-
ment of synaptic function in wild type (Wt, n=8), APPswe/PS1dE9
(AD, n=6), and APPswe/PS1dE9/Hsp27 (ADHSP, n=7) mice using
PPF. There was no significant difference in PPF values of different
genotypes. c TBS induced LTP in transgenic (AD and ADHSP) and
wild type mice. d Bar graph shows the fEPSP amplitude means of the
last 5 min of LTP. Asterisk denotes p≤0.05 analyzed by ANOVA and
post hoc Bonferroni test
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amyloid aggregation and plaque formation, or it can facilitate
amyloid clearance and degradation in the brain.
Neuronal apoptosis
We used anti-active caspase-3 antibody and Fluoro-Jade C
stainings tomonitor apoptosis and neurodegeneration in the brain
of 7-month-old transgenic mice. Activation of effector caspase-3
molecules triggers the activation of caspase cascade, which
eventually leads to apoptosis of the cells (Boatright and Salvesen
2003). Fluoro-Jade C is an anionic fluorochrome, which sensi-
tively and specifically binds to degenerating neurons (Schmued
et al. 2005). We detected significantly increased number of
apoptotic cells (Fig. 5a) and degenerated neurons (Fig. 5b) in
the hippocampal as well as cortical regions of APPswe/PS1dE9
and APPswe/PS1dE9/Hsp27 transgenic brains compared to wild
type animals (p<0.001); however, there was no statistical differ-
ence between AD model mice and AD model mice expressing
Hsp27.
Gene expression analysis of Hsp27 transgenic mice
Results obtained above indicated that Hsp27, as a molecular
chaperone, might have a role in inhibition of amyloid
Fig. 4 Immunostaining of hippocampal (a) and cortical (b) amyloid
plaques in 7 months old APPswe/PS1dE9, APPswe/PS1dE9/Hsp27
transgenic, and wild type (Wt) mice. Arrows indicate the presence of
amyloid deposits. c Number of Aβ deposits/field of view in wild type
(Wt, n=6), APPswe/PS1dE9 (n=6), and APPswe/PS1dE9/Hsp27 mice
(n=6; mean ± SEM is shown; *p<0.05)
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Fig. 5 Quantitative comparison of apoptotic cell (a) and degenerating
neuron (b) numbers in the hippocampus and cortex of 7 months old
wild type (Wt, n=6), APPswe/PS1dE9 (n=6), and APPswe/PS1dE9/
Hsp27 (n=6) mice. Apoptotic cells were detected by anti-active
caspase-3 antibody staining, while degenerating neurons were visual-
ized using Fluoro-Jade C staining. Mean ± SEM is shown
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accumulation/deposition or in enhanced amyloid clearing
and degradation. In order to clarify its molecular role, we
monitored the gene expression of several genes potentially
involved in β-amyloid metabolism such as APP, ApoA1,
ApoD, ApoE, LDLr, Lrp1, Lrp2, Hsp90, and neurodegeneration
(NOS1 and NOS2) in the cortex of Hsp27 transgenic mice using
Q-PCR. Primers used in this study are listed in Table 1. The
expression level of ApoD and Lrp2 was slightly increased
(128 % and 128 %, respectively), in the brain of Hsp27 trans-
genic mice compared to wild type controls (100 %), whereas
there was no change in the mRNA level of APP, ApoE, LDLr,
Lrp1, Hsp90, NOS1, and NOS3. Rather surprisingly, cortical
expression of ApoA1 was reduced by half in Hsp27 transgenics
versus wild type mice (Fig. 6a). Decreased ApoA1 expression in
Hsp27 transgenic mice was further confirmed using western
blotting. ApoA1 protein level was reduced in Hsp27 transgenic
mice (61.1%), but slightly elevated inADmodelmice (126.7%)
compared to wild types (100 %). However, AD mice
overexpressing human Hsp27 protein possessed similar ApoA1
protein level than wild type mice, indicating that Hsp27
influenced ApoA1 expression (Fig. 6b, c).
Discussion
In this study, we investigated the effects of small heat shock
protein, Hsp27, on the development of AD-related pheno-
types in transgenic mice. For this purpose, we used
APPswe/PS1dE9 transgenic strain. These mice develop sev-
eral AD-related phenotype including amyloid-beta deposits,
abnormal spatial memory, axon degeneration, and synapse
loss (The Jackson Laboratory (2013)) (http://jaxmice.jax.org/
strain/004462.html). We overexpressed the human Hsp27
protein in AD model mice and monitored learning and
memory, synaptic function, amyloid deposition, and neuronal
apoptosis in the triple transgenic mice.
Decline of the short-term memory is among the primary
symptoms in AD patients. We found that spatial learning
was impaired in APPswe/PS1dE9 mice as the time required
to find the escape hole in Barnes maze test, or the platform
in Morris water maze test was significantly longer compared
to wild type mice. However, the performance of
APPswe/PS1dE9/Hsp27 group was similar to the wild type
group in both tests, which suggests that overexpression of
Hsp27 protein ameliorates learning and memory deficits.
We have also found that synaptic excitability was in-
creased in AD model mice, but this was normalized by
Hsp27 overexpression. This is in accordance with earlier
findings of others who demonstrated that seizure suscepti-
bility is increased in AD model mice (Westmark et al. 2008;
Vogt et al. 2009), and heat shock proteins can moderate
chemically induced seizures (Akbar et al. 2003; Ekimova
et al. 2010). LTP, a cellular correlate of learning and
memory (Bliss and Colingridge 1993), was also investigated
on hippocampal slices. Previously, it was demonstrated that
soluble oligomers of Aβ are able to inhibit LTP and cause
learning and memory deficit (Haas and Selkoe 2007; Bozso
et al. 2010). Our results have shown that LTP was impaired
in APPswe/PS1dE9 mice indeed, but it was normalized
upon Hsp27 overexpression. There is substantial evidence
from transgenic mouse models that intracellular Aβ initiates
cellular dysfunction, synaptic, electrophysiological, and be-
havioral changes before it accumulates in extracellular
plaques (Moechars et al. 1999; Kumar-Singh et al. 2000;
Mucke et al. 2000). The toxic Aβ molecules (either soluble
oligomers or fibrillar forms) might initiate a cascade, which
finally leads to neuronal dysfunction. Therefore, inhibition
of Aβ oligomerization and deposition or enhanced clear-
ance of Aβ might play a crucial role in the prevention and
therapy of AD. We have found a significantly lower level of
amyloid deposition in the brain of AD/Hsp27 animals com-
pared to the AD group, indicating that Hsp27 is somehow
involved in these processes. In AD, heat shock protein
expression is associated with Aβ deposition and neurofi-
brillary tangles, and recent findings suggest that Hsps pre-
vent the accumulation of Aβ (Abdul et al. 2006; Evans et al.
2006). Wilhelmus et al. (2006) demonstrated that Hsp20,
Hsp27, and αB-crystallin bind strongly to Aβ and inhibit its
aggregation. Furthermore, Hsp20, Hsp27, and αB-crystallin
inhibited cerebrovascular Aβ toxicity, probably by reducing
the accumulation of Aβ at the cell surface.
Aggregated forms of Aβ might lead to neurodegeneration
through different pathways. Several studies have shown that
chronic inflammatory response to deposited amyloid resulted
in neurodegeneration (Akiyama et al. 2000; Wyss-Coray and
Mucke 2002). Although heat shock proteins have protective
effects in neurodegenerative disease models, the molecular
basis of this protection is not fully understood. It is likely that
heat shock proteins have effect at several levels, and their
neuroprotective function might not be linked exclusively to
their effect on protein aggregation (Muchowski and Wacker
2005). For example, Hsps are known to reduce oxidative
stress and mediate apoptotic pathway. They can also facilitate
proteasomal degradation, which might help in Aβ clearance.
However, the exact molecular mechanisms of Aβ-induced
neurotoxicity are not fully known. Thesemechanisms are very
diverse, and probably include the increased production of
reactive oxygen species (ROS), altered calcium homeostasis,
and enzyme activities. Several lines of evidence are available
suggesting that Aβ can interact with artificial and biological
membranes altering their fluidity. Altered membrane fluidity
can influence the function of other membrane components.
Certain studies suggest that the insertion of Aβ into the
plasma membrane triggers different events catalyzed by per-
turbation of the conformation of membrane proteins, which
finally leads to neurotoxicity (Kanfer et al. 1999). This
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hypothesis suggests that the neurotoxic cascade of Aβ is
initiated in the cell membrane. It is also important, that α-,
β-, and γ-secretases are associated with cellular membranes;
thereby, their function, such as APP processing, strongly de-
pends on membrane fluidity. Peters et al. (2009) showed that
oligomeric Aβ can reduce membrane fluidity, which in turn
stimulates the amyloidogenic processing of APP. Several
studies suggest that a subpopulation of Hsps is present either
on the surface or within the cellular membranes, and they have
been shown to modulate major attributes of the membrane
lipid phase such as fluidity and permeability. By stabilizing
the membrane, Hsps can restore membrane functionality dur-
ing stress conditions (Horváth et al. 2008). We can suppose
that Hsp27 also can interact with and stabilize cellular mem-
branes; thereby, it can diminish the level of Aβ-induced
neurotoxic cascade or, moreover, the production of Aβ. The
generation of ROS is also a crucial factor in the molecular
mechanisms of Aβ-induced neurotoxicity. Lipid peroxidation,
and protein and DNA oxidation are remarkable in the brain of
AD patients, and Aβmight have a central role in the induction
of these processes (reviewed in Butterfield et al. 2001). Hsp27
has a protective effect in oxidative stress; thereby, Hsp27
might eliminate the neurotoxicity of Aβ at least in part due
to this property.
To know more about the role of Hsp27 in amyloid me-
tabolism—whether it inhibits APP production or enhances
amyloid clearance/degradation—we performed gene expres-
sion analysis. No decrease in APP production was detected;
however, a subtle elevation of ApoD and LRP1 protein
levels in Hsp27 transgenic brains was observed. Although
ApoD and LRP1 proteins have important roles in
neuroprotection and Aβ clearance, respectively (Terrise at
al. 1998; Kalman et al. 2000; Thomas et al. 2001; Muffat et
al. 2008; Kang et al. 2000), we do not consider that the mild
changes obtained in their expression would be sufficiently
enough to lead to efficient reduction of amyloid plaque
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Fig. 6 Gene expression
profiles of different genes
involved in amyloid
metabolism in Hsp27
transgenic mice using Q-PCR
analysis (a). Data was
normalized to the endogenous
β-actin, then expressed as a
percent of wild type expression
(100 %). b Representative
western blot of ApoA1
expression in Hsp27 transgenic
(Hsp27), wild type (Wt), AD
model (APPswe/PS1dE9), and
AD/Hsp27 (APPswe/PS1dE9/
Hsp27) brains. c Statistical
analysis of western blot
experiment. Hsp27 transgenic
(n=5), wild type (Wt, n=6),
AD model (n=5), and AD/Hsp
triple transgenic mice (n=6)
were compared
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numbers. Now it is widely accepted that ApoD is elevated in
many neuropathological conditions, including Alzheimer's
disease, Parkinson's disease, stroke, schizophrenia, and bi-
polar disorder. It was also demonstrated that in Drosophila,
overexpressed ApoD had a protective effect against oxida-
tive stress and heat shock (Muffat et al. 2008). In vitro LDL
receptor-related protein 1 (LRP1) mediates the clearance of
both Aβ 40 and Aβ 42 through a bona fide receptor-
mediated uptake (Kang et al. 2000); therefore, LRP and its
ligand ApoE have been proposed to be a clearance pathway
for Aβ. At the same time, the role of ApoA1 in amyloid
metabolism and AD pathology is controversial. Although it
has been shown that ApoA1 inhibits Aβ aggregation in vitro
(Koldamova et al. 2001), in vivo studies resulted different
results. Crossing of ApoA1 null mice with AD model mice
resulted no change in amyloid deposition in the brain (Fagan
et al. 2004). Similarly, when ApoA1 overexpressing mice
were crossed with AD model mice, no alteration in amyloid
metabolism was observed (Lewis et al. 2010). Our result
presented here shows that expression of ApoA1 was
downregulated in Hsp27 transgenic mice, indicating that
Hsp27 might have a role in the regulation (directly or
indirectly) of ApoA1 expression.
Taken together, further investigations are necessary to
reveal the exact molecular pathways involved in
neuroprotective function of Hsp27.
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